 Craig Smail
Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multifactorial Inheritance | 4 | 2022 | 10 | 1.310 |
Why?
| | Obesity | 1 | 2022 | 124 | 0.790 |
Why?
| | Genetic Variation | 6 | 2021 | 161 | 0.670 |
Why?
| | Rare Diseases | 3 | 2022 | 37 | 0.420 |
Why?
| | Transcriptome | 2 | 2021 | 50 | 0.380 |
Why?
| | Humans | 15 | 2023 | 6599 | 0.360 |
Why?
| | Quantitative Trait Loci | 3 | 2021 | 64 | 0.290 |
Why?
| | Genome-Wide Association Study | 3 | 2022 | 181 | 0.290 |
Why?
| | High-Throughput Nucleotide Sequencing | 3 | 2022 | 94 | 0.250 |
Why?
| | Chromatin | 1 | 2023 | 20 | 0.230 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2021 | 340 | 0.230 |
Why?
| | Trophoblasts | 1 | 2023 | 15 | 0.230 |
Why?
| | Mutation | 2 | 2021 | 194 | 0.230 |
Why?
| | Genome, Human | 2 | 2020 | 82 | 0.220 |
Why?
| | Central Nervous System Stimulants | 1 | 2022 | 10 | 0.210 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 17 | 0.210 |
Why?
| | Nonsense Mediated mRNA Decay | 1 | 2021 | 1 | 0.210 |
Why?
| | Codon, Nonsense | 1 | 2021 | 6 | 0.210 |
Why?
| | Genetic Diseases, Inborn | 1 | 2021 | 18 | 0.200 |
Why?
| | Phenotype | 1 | 2022 | 233 | 0.200 |
Why?
| | Population | 1 | 2021 | 2 | 0.200 |
Why?
| | Body Mass Index | 1 | 2022 | 155 | 0.200 |
Why?
| | Disease | 1 | 2021 | 7 | 0.200 |
Why?
| | Primary Health Care | 2 | 2020 | 44 | 0.200 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 2 | 0.200 |
Why?
| | RNA, Long Noncoding | 1 | 2021 | 14 | 0.200 |
Why?
| | Genomics | 1 | 2022 | 86 | 0.200 |
Why?
| | RNA, Messenger | 1 | 2021 | 107 | 0.200 |
Why?
| | Genetic Predisposition to Disease | 1 | 2022 | 215 | 0.190 |
Why?
| | Gene Expression Regulation | 1 | 2021 | 98 | 0.190 |
Why?
| | Risk Factors | 1 | 2022 | 460 | 0.190 |
Why?
| | Microsatellite Repeats | 1 | 2020 | 7 | 0.190 |
Why?
| | Physicians, Family | 1 | 2020 | 1 | 0.190 |
Why?
| | Herpes Zoster Vaccine | 1 | 2020 | 2 | 0.190 |
Why?
| | Reminder Systems | 1 | 2020 | 5 | 0.190 |
Why?
| | Pneumococcal Vaccines | 1 | 2020 | 4 | 0.190 |
Why?
| | Quality Indicators, Health Care | 1 | 2020 | 17 | 0.190 |
Why?
| | Influenza Vaccines | 1 | 2020 | 24 | 0.180 |
Why?
| | Vaccination | 1 | 2020 | 68 | 0.180 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2019 | 8 | 0.170 |
Why?
| | Pathology, Clinical | 1 | 2018 | 1 | 0.170 |
Why?
| | Laboratory Proficiency Testing | 1 | 2018 | 2 | 0.170 |
Why?
| | Medical Oncology | 1 | 2018 | 18 | 0.170 |
Why?
| | Health Services Misuse | 1 | 2017 | 1 | 0.160 |
Why?
| | Family Practice | 1 | 2018 | 4 | 0.160 |
Why?
| | Community Health Services | 1 | 2018 | 9 | 0.160 |
Why?
| | Patient Participation | 1 | 2018 | 21 | 0.160 |
Why?
| | Immunization | 1 | 2017 | 23 | 0.160 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2018 | 62 | 0.160 |
Why?
| | Quality Improvement | 1 | 2017 | 60 | 0.150 |
Why?
| | Cell Line | 3 | 2021 | 80 | 0.140 |
Why?
| | Organ Specificity | 2 | 2021 | 22 | 0.100 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 23 | 0.090 |
Why?
| | Female | 3 | 2023 | 3436 | 0.080 |
Why?
| | United States | 2 | 2020 | 646 | 0.070 |
Why?
| | Adult | 2 | 2022 | 1233 | 0.070 |
Why?
| | Cell Lineage | 1 | 2023 | 17 | 0.060 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2023 | 13 | 0.060 |
Why?
| | Placenta | 1 | 2023 | 19 | 0.060 |
Why?
| | Placentation | 1 | 2023 | 15 | 0.060 |
Why?
| | Transcription Factors | 1 | 2023 | 46 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2023 | 41 | 0.060 |
Why?
| | Pregnancy | 1 | 2023 | 203 | 0.050 |
Why?
| | Genome | 1 | 2022 | 30 | 0.050 |
Why?
| | Pedigree | 1 | 2022 | 53 | 0.050 |
Why?
| | Child | 2 | 2022 | 3146 | 0.050 |
Why?
| | Sequence Analysis, DNA | 1 | 2022 | 106 | 0.050 |
Why?
| | Male | 2 | 2020 | 3197 | 0.050 |
Why?
| | Coronary Artery Disease | 1 | 2021 | 10 | 0.050 |
Why?
| | Bardet-Biedl Syndrome | 1 | 2021 | 1 | 0.050 |
Why?
| | Cerebellar Ataxia | 1 | 2021 | 4 | 0.050 |
Why?
| | Calcium Channels | 1 | 2021 | 7 | 0.050 |
Why?
| | Gene Frequency | 1 | 2021 | 88 | 0.050 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2021 | 16 | 0.050 |
Why?
| | Proteins | 1 | 2021 | 22 | 0.050 |
Why?
| | Gene Expression | 1 | 2021 | 60 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 109 | 0.050 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2021 | 40 | 0.050 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 44 | 0.050 |
Why?
| | Linkage Disequilibrium | 1 | 2020 | 34 | 0.050 |
Why?
| | Staff Development | 1 | 2020 | 2 | 0.050 |
Why?
| | Task Performance and Analysis | 1 | 2020 | 4 | 0.050 |
Why?
| | Immunization Programs | 1 | 2020 | 6 | 0.050 |
Why?
| | DNA Methylation | 1 | 2021 | 108 | 0.050 |
Why?
| | Self Report | 1 | 2020 | 43 | 0.050 |
Why?
| | Program Evaluation | 1 | 2020 | 52 | 0.050 |
Why?
| | Patient Education as Topic | 1 | 2020 | 64 | 0.040 |
Why?
| | Potassium Channels | 1 | 2019 | 1 | 0.040 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 2019 | 1 | 0.040 |
Why?
| | Acid Ceramidase | 1 | 2019 | 1 | 0.040 |
Why?
| | RNA | 1 | 2019 | 14 | 0.040 |
Why?
| | RNA Splicing | 1 | 2019 | 11 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2021 | 108 | 0.040 |
Why?
| | Models, Genetic | 1 | 2019 | 33 | 0.040 |
Why?
| | Databases, Nucleic Acid | 1 | 2019 | 3 | 0.040 |
Why?
| | Lymphocytes | 1 | 2019 | 15 | 0.040 |
Why?
| | Receptors, Calcitriol | 1 | 2019 | 9 | 0.040 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2019 | 14 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2019 | 202 | 0.040 |
Why?
| | Computational Biology | 1 | 2019 | 40 | 0.040 |
Why?
| | Genetic Association Studies | 1 | 2019 | 53 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2019 | 64 | 0.040 |
Why?
| | Cohort Studies | 1 | 2019 | 264 | 0.040 |
Why?
| | Algorithms | 1 | 2019 | 103 | 0.040 |
Why?
| | Middle Aged | 1 | 2020 | 648 | 0.040 |
Why?
| | Health Services Research | 1 | 2018 | 5 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2018 | 197 | 0.040 |
Why?
| | Terminology as Topic | 1 | 2017 | 14 | 0.040 |
Why?
| | Child, Preschool | 1 | 2019 | 1459 | 0.030 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|